[Factors associated with long-term prognosis after ischemic stroke treated with fibrinolytic agents]. 2015

Alejandro Gallardo Tur, and Natalia García Casares, and Carlos de la Cruz Cosme, and Marta Jiménez Parras, and Francisco Temboury Ruiz, and Eduardo Rosell Vergara, and Manuel Márquez Martínez, and Óscar Fernández Fernández
UGC Intercentros de Neurociencias, Instituto de Investigación Biomédica de Málaga (IBIMA), Hospitales Universitarios Regional de Málaga y Virgen de la Victoria, Málaga, España.

OBJECTIVE To analyze the variables associated with better functional outcome 3 months after ischemic stroke treated with fibrinolytic agents. METHODS The cases of 63 patients with characteristics leading to activation of a stroke code were analyzed retrospectively. The patients received fibrinolytic therapy in a referral hospital for the western district of Malaga, Spain. We recorded the time until start of fibrinolytic therapy, severity according to the National Institute of Health Stroke Scale (NIHSS) at baseline and at 24 hours, and functional outcome at 3 months according to the modified Rankin Scale. RESULTS Data for 63 patients with a mean (SD) age of 65 (11) years were included. The mean time until start of fibrinolytic therapy was 151 (42) minutes. The mean NIHSS scores were 15.5 (4.8) points at baseline and 9.1 (7.13) at 24 hours. The mean change in score at 24 hours was 6.3 (5.8) points. The findings of correlation analysis between scores on the modified Rankin scale and other variables were as follows: NIHSS score at 24 hours, ρ = 0.73; P < .01; NIHSS at baseline, ρ = 0.34; P = .01); age, ρ = 0.41; P = .001); time until start of fibrinolysis, ρ = 0.21; P = .09); change in NIHSS score at 24 hours, ρ = -0.61; P = .001). CONCLUSIONS The prognosis for the functional recovery of patients given intravenous fibrinolytic therapy after stroke depends on such factors as age, time treatment is started, severity, and the patient's status at 24 hours. The last factor is the one that is most strongly related to prognosis.

UI MeSH Term Description Entries

Related Publications

Alejandro Gallardo Tur, and Natalia García Casares, and Carlos de la Cruz Cosme, and Marta Jiménez Parras, and Francisco Temboury Ruiz, and Eduardo Rosell Vergara, and Manuel Márquez Martínez, and Óscar Fernández Fernández
October 2019, Stroke,
Alejandro Gallardo Tur, and Natalia García Casares, and Carlos de la Cruz Cosme, and Marta Jiménez Parras, and Francisco Temboury Ruiz, and Eduardo Rosell Vergara, and Manuel Márquez Martínez, and Óscar Fernández Fernández
January 2017, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association,
Alejandro Gallardo Tur, and Natalia García Casares, and Carlos de la Cruz Cosme, and Marta Jiménez Parras, and Francisco Temboury Ruiz, and Eduardo Rosell Vergara, and Manuel Márquez Martínez, and Óscar Fernández Fernández
February 2018, Neurology,
Alejandro Gallardo Tur, and Natalia García Casares, and Carlos de la Cruz Cosme, and Marta Jiménez Parras, and Francisco Temboury Ruiz, and Eduardo Rosell Vergara, and Manuel Márquez Martínez, and Óscar Fernández Fernández
March 1981, Acta neurologica Scandinavica,
Alejandro Gallardo Tur, and Natalia García Casares, and Carlos de la Cruz Cosme, and Marta Jiménez Parras, and Francisco Temboury Ruiz, and Eduardo Rosell Vergara, and Manuel Márquez Martínez, and Óscar Fernández Fernández
April 2014, Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia,
Alejandro Gallardo Tur, and Natalia García Casares, and Carlos de la Cruz Cosme, and Marta Jiménez Parras, and Francisco Temboury Ruiz, and Eduardo Rosell Vergara, and Manuel Márquez Martínez, and Óscar Fernández Fernández
November 1992, Acta neurologica Scandinavica,
Alejandro Gallardo Tur, and Natalia García Casares, and Carlos de la Cruz Cosme, and Marta Jiménez Parras, and Francisco Temboury Ruiz, and Eduardo Rosell Vergara, and Manuel Márquez Martínez, and Óscar Fernández Fernández
December 2010, Stroke research and treatment,
Alejandro Gallardo Tur, and Natalia García Casares, and Carlos de la Cruz Cosme, and Marta Jiménez Parras, and Francisco Temboury Ruiz, and Eduardo Rosell Vergara, and Manuel Márquez Martínez, and Óscar Fernández Fernández
January 2021, Acta neurologica Scandinavica,
Alejandro Gallardo Tur, and Natalia García Casares, and Carlos de la Cruz Cosme, and Marta Jiménez Parras, and Francisco Temboury Ruiz, and Eduardo Rosell Vergara, and Manuel Márquez Martínez, and Óscar Fernández Fernández
November 2017, American journal of hypertension,
Alejandro Gallardo Tur, and Natalia García Casares, and Carlos de la Cruz Cosme, and Marta Jiménez Parras, and Francisco Temboury Ruiz, and Eduardo Rosell Vergara, and Manuel Márquez Martínez, and Óscar Fernández Fernández
April 2007, Cardiovascular drugs and therapy,
Copied contents to your clipboard!